IOA-289

· iOnctura

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IOA-289, covering 2025-03-20 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]